Dipeptidyl相关论文
Dipeptidyl peptidase-4 inhibitors(DPP-4i)have an important place in the management of type 2 diabetes.The DPP-4 enzyme i......
BACKGROUND The efficacy of novel glucose-lowering drugs in treating non-alcoholic fatty liver disease(NAFLD)is unknown.A......
AIM:To investigate the expression of dipeptidyl peptidase(DPP) 8 and DPP9 in lymphocytes and various models of liver fib......
AIM:To investigate the mechanism and in vivo effects of MK-0626,a dipeptidyl peptidase-4 inhibitor,on hepatic steatosis ......
Describing a reported case of acute pancreatitis in a patient receiving sitagliptin. We present the biochemical and find......
Efficacy of anagliptin as compared to linagliptin on metabolic parameters over 2 years of drug consu
AIM To evaluate the comparative effectiveness of anagliptin and linagliptin on the clinical parameters in patients with ......
目的利用蛋白质组学方法，寻找与RAEB（refractory anemia with excess blasts in transformation）型骨髓增生异常综合征（MDS）相关的特异......
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E3024, a Novel and Selective Dipeptid
E3024 (3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate) is a dipeptidyl pep......
The Possible Role of the Incretin Enhancer Sitaglipten, in Renal Ischemic Reperfusion Injury in Type
Background: Diabetes mellitus (DM) especially type 2 is a major health problem and diabetic nephropathy is the main caus......
Background: There are few clinical trials addressing the difference in pleiotropic effects among dipeptidyl peptidase (D......
Effect of Urena lobataleaves extract on glucagon like peptide-1 serum level by inhibition of dipepti
OBJECTIVE To investigate effect of Urenalobataleaves extract on glucagon like peptide-1(GLP-1)serum level by inhibition ......
Low expression of angiotensinogen and dipeptidyl peptidase 1 in saliva of patients with proliferativ
AIM To elucidate the profile of the salivary proteome.METHODS Unstimulated whole mouth saliva was collected from 30 volu......
Risk of pancreatic adverse events associated with the use of glucagon-like peptide-1 receptor agonis
...
The addition of the dipeptidyl peptidase-4 (DDP-4) inhibitor has been reported to achieve greater improvements in glucos......
AIM:To evaluate the efficacy and safety of the addition of vildagliptin to low-dose metformin and compare it to an uptit......
AIM To study the effects of linagliptin on the structural signs of non-alcoholic fatty liver disease (NAFLD) in db /db m......
Diabetes is the most important risk factors for chronic kidney disease(CKD). The risk of CKD attributable to diabetes co......
In recent years the treatment focus for type 2 diabetes has shifted to prevention by lifestyle change and to more aggres......
Ischemic stroke is a leading cause of mortality and long-term disability worldwide. Given the detrimental effects of acu......
Prediction of the effect on antihyperglycaemic action of sitagliptin by plasma active form glucagon-
AIM: To investigate whether active glucagon-like peptide-1 (GLP-1) is a prediction Factor of Effect of sitagliptin on pa......
